{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T04:56:58Z","timestamp":1689829018157},"reference-count":16,"publisher":"Medical Association of Nippon Medical School","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1272\/jnms.79.471","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T22:04:16Z","timestamp":1425420256000},"page":"471-477","source":"Crossref","is-referenced-by-count":3,"title":["A Neonate with Reduced Cytomegalovirus DNA Copy Number and Marked Improvement of Hearing in the Treatment of Congenital Cytomegalovirus Infection"],"prefix":"10.1272","volume":"79","author":[{"given":"Jun","family":"Hayakawa","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"},{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"},{"name":"Department of Handicapped Children's Support, Shimada Center for Rehabilitation and Neurodevelopmental Intervention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Fukazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Takase","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School Tama Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"21","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Grosse SD, Ross DS, Dollard SC: Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008; 41: 57-62.","DOI":"10.1016\/j.jcv.2007.09.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fowler KB, Dahle AJ, Boppana SB, Pass RF: Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999; 135: 60-64.","DOI":"10.1016\/S0022-3476(99)70328-8"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Whitley RJ, Cloud G, Gruber W, et al.: Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997; 175: 1080-1086.","DOI":"10.1086\/516445"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kimberlin DW, Lin CY, Sanchez PJ, et al.: Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003; 143: 16-25.","DOI":"10.1016\/S0022-3476(03)00192-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Numazaki K, Fujikawa T: Chronological changes of incidence and prognosis of children with asymptomatic congenital cytomegalovirus infection in Sapporo, Japan. BMC Infect Dis 2004; 4: 22.","DOI":"10.1186\/1471-2334-4-22"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bate SL, Dollard SC, Cannon MJ: Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010; 50: 1439-1447.","DOI":"10.1086\/652438"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dobyns WB, Elias ER, Newlin AC, Pagon RA, Ledbetter DH: Causal heterogeneity in isolated lissencephaly. Neurology 1992; 42: 1375-1388.","DOI":"10.1212\/WNL.42.7.1375"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nigro G, Adler SP, La Torre R, Best AM: Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353: 1350-1362.","DOI":"10.1056\/NEJMoa043337"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jacquemard F, Yamamoto M, Costa JM, et al.: Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. Bjog 2007; 114: 1113-1121.","DOI":"10.1111\/j.1471-0528.2007.01308.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF: Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130: 624-630.","DOI":"10.1016\/S0022-3476(97)70248-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Amir J, Wolf DG, Levy I: Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr 2010; 169: 1061-1067.","DOI":"10.1007\/s00431-010-1176-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huygen PL, Admiraal RJ: Audiovestibular sequelae of congenital cytomegalovirus infection in 3 children presumably representing 3 symptomatically different types of delayed endolymphatic hydrops. Int J Pediatr Otorhinolaryngol 1996; 35: 143-154.","DOI":"10.1016\/0165-5876(96)83899-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ramirez Inscoe JM, Nikolopoulos TP: Cochlear implantation in children deafened by cytomegalovirus: speech perception and speech intelligibility outcomes. Otol Neurotol 2004; 25: 479-482.","DOI":"10.1097\/00129492-200407000-00014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pyman B, Blamey P, Lacy P, Clark G, Dowell R: The development of speech perception in children using cochlear implants: effects of etiologic factors and delayed milestones. Am J Otol 2000; 21: 57-61.","DOI":"10.1016\/S0196-0709(00)80113-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ciorba A, Bovo R, Trevisi P, Bianchini C, Arboretti R, Martini A: Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infection. Eur Arch Otorhinolaryngol 2009; 266: 1539-1546.","DOI":"10.1007\/s00405-009-0944-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Azevedo RS, Amaku M: Modelling immunization strategies with cytomegalovirus vaccine candidates. Epidemiol Infect 2011; 1-9.","DOI":"10.1017\/S0950268811000343"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/79\/6\/79_471\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:38:42Z","timestamp":1498199922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/79\/6\/79_471\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.79.471","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}